PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
195 hedge funds and large institutions have $421M invested in PDL BioPharma, Inc. in 2016 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 74 increasing their positions, 61 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less call options, than puts
Call options by funds: $1.52M | Put options by funds: $2.76M
Holders
195
Holding in Top 10
–
Calls
$1.52M
Puts
$2.76M
Top Buyers
| 1 | +$7.92M | |
| 2 | +$7.53M | |
| 3 | +$4.21M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$3.69M |
| 5 |
QI
QS Investors
New York
|
+$3.31M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$7.85M | |
| 3 | -$5.33M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$4.07M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$3.78M |